INFLIXIMAB

infliximab 120 mg/mL injection, 1 mL syringe

INFLIXIMAB (12597B)

infliximab 120 mg/mL injection, 1 mL syringe
12597B
Body System:
Manner of administration:Injection
General Schedule
Authority Required

Restriction

Indication: Severe Crohn disease
Treatment phase: Balance of supply for Initial treatment - subcutaneous form
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 2 Max qty units: 2 # of repeats: 0 DPMQ: $760.24 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Remsima SC